drug
NVCov-2R
Preclinicalupdated 3mo agoby $NNVC NANOVIRICIDES, INC.
Preclinicalcommunity read0 votes
🐶 often sniffed alongside
top 3all catalysts(0)
nothing on the calendar yet
Trials studying NVCov-2R
- phase3A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- phase2Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals
- —Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infants
- phase3ACTIV-3b: Therapeutics for Severely Ill Inpatients With COVID-19
- phase3Remdesivir for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)
- phase2Safety and Effectiveness of a Remdesivir Treatment to Prevent Severe COVID-19 in Kidney Transplant Patients
- N/ASARS-CoV-2 Human Challenge Characterisation Study
- phase1A Study of CX2101A Enteric-Coated Tablets in Healthy Chinese Adult Subjects
News(5)
- Opinion: We prepared for Ebola — but not this Ebola“Preparedness cannot mean optimizing every investment for yesterday's epidemic,” write Krutika Kuppalli and Placide Mbala.stat · 10d ago
- Opinion: We prepared for Ebola — but not this Ebola“Preparedness cannot mean optimizing every investment for yesterday's epidemic,” write Krutika Kuppalli and Placide Mbala.stat · 10d ago
- The race for an Ebola therapy beginsMale marathoners "hit the wall," mental health in 2026, and more Morning Rounds newsstat · 1mo ago
- STAT+: Pharmalittle: We’re reading about Replimune drug getting third try at FDA approval, a Pfizer deal in China, and morePharma updates from the Pharmalot campus via the Pharmalittle newsletterstat · 2mo ago
- Which vaccines will curb the Ebola outbreak? WHO debatesThe growing Ebola outbreak, the unknowns of microdosing GLP-1s, and more health news from Morning Roundsstat · 2mo ago
Data sources
last refreshed 35m ago
Found something off?
comments(0)
5-min edit window · permanent after that